Tratamiento de la colitis ulcerosa fulminante refractaria con anticuerpos quiméricos anti-CD25

Statistics

Chimeric anti-CD25 antibody in the treatment of refractory fulminating ulcerative colitis

P.. Oliver-Goicoleaa,

Corresponding author

pablo.olivergoicolea@osakidetza.net

Autor para correspondencia. pablo.olivergoicolea@osakidetza.net

, I.. Irastorza-Terradillosa, J.C.. Vitoria-Cormenzanaa

a Sección de Gastroenterología y Nutrición Pediátricas, Hospital Universitario de Cruces, Universidad del País Vasco-EHU, Barakaldo, Vizcaya, España

Read

15513

Times
was read the article

3140

Total PDF

12373

Total HTML

Share statistics

Article information

ISSN: 16954033
Original language: Spanish

DOI:10.1016/j.anpedi.2010.12.014

The statistics are updated each day

Year/Month	Html	Pdf	Total
2026 1	122	66	188
2025 12	191	137	328
2025 11	96	64	160
2025 10	89	44	133
2025 9	84	52	136
2025 8	91	78	169
2025 7	99	48	147
2025 6	81	101	182
2025 5	117	26	143
2025 4	163	24	187
2025 3	140	36	176
2025 2	152	24	176
2025 1	88	21	109
2024 12	99	43	142
2024 11	96	52	148
2024 10	93	46	139
2024 9	110	33	143
2024 8	104	45	149
2024 7	93	39	132
2024 6	93	23	116
2024 5	98	27	125
2024 4	85	37	122
2024 3	76	34	110
2024 2	72	29	101
2024 1	100	25	125
2023 12	111	21	132
2023 11	95	40	135
2023 10	121	33	154
2023 9	73	30	103
2023 8	69	27	96
2023 7	92	51	143
2023 6	93	30	123
2023 5	108	24	132
2023 4	73	14	87
2023 3	108	23	131
2023 2	83	30	113
2023 1	69	15	84
2022 12	80	21	101
2022 11	103	42	145
2022 10	99	52	151
2022 9	93	30	123
2022 8	69	56	125
2022 7	66	31	97
2022 6	71	36	107
2022 5	98	35	133
2022 4	94	36	130
2022 3	133	47	180
2022 2	113	25	138
2022 1	121	38	159
2021 12	119	38	157
2021 11	119	45	164
2021 10	127	46	173
2021 9	64	42	106
2021 8	54	28	82
2021 7	59	35	94
2021 6	65	26	91
2021 5	74	19	93
2021 4	177	81	258
2021 3	150	42	192
2021 2	85	16	101
2021 1	97	15	112
2020 12	106	13	119
2020 11	74	14	88
2020 10	78	19	97
2020 9	84	9	93
2020 8	61	11	72
2020 7	72	15	87
2020 6	86	16	102
2020 5	58	21	79
2020 4	75	16	91
2020 3	56	18	74
2020 2	67	18	85
2020 1	66	21	87
2019 12	71	22	93
2019 11	52	11	63
2019 10	69	8	77
2019 9	49	14	63
2019 8	71	16	87
2019 7	94	20	114
2019 6	82	27	109
2019 5	103	27	130
2019 4	83	32	115
2019 3	62	35	97
2019 2	74	14	88
2019 1	50	27	77
2018 12	66	22	88
2018 11	98	22	120
2018 10	107	24	131
2018 9	65	7	72
2018 8	4	0	4
2018 7	5	0	5
2018 6	9	0	9
2018 5	14	0	14
2018 4	71	0	71
2018 3	93	0	93
2018 2	50	0	50
2018 1	52	1	53
2017 12	50	0	50
2017 11	40	0	40
2017 10	42	0	42
2017 9	32	0	32
2017 8	38	0	38
2017 7	39	0	39
2017 6	33	13	46
2017 5	40	7	47
2017 4	42	11	53
2017 3	39	2	41
2017 2	161	2	163
2017 1	59	2	61
2016 12	68	5	73
2016 11	105	7	112
2016 10	92	9	101
2016 9	136	6	142
2016 8	75	7	82
2016 7	40	9	49
2016 6	3	0	3
2016 5	3	0	3
2016 4	1	0	1
2016 3	3	0	3
2016 2	2	0	2
2016 1	3	0	3
2015 12	3	0	3
2015 11	1	0	1
2015 10	3	0	3
2015 9	1	0	1
2015 8	3	22	25
2015 7	9	0	9
2015 6	9	0	9
2015 5	7	16	23
2015 4	12	22	34
2015 3	13	0	13
2015 2	14	5	19
2015 1	14	1	15
2014 12	26	2	28
2014 11	15	3	18
2014 10	22	6	28
2014 9	21	5	26
2014 8	29	4	33
2014 7	27	7	34
2014 6	38	2	40
2014 5	55	6	61
2014 4	48	2	50
2014 3	64	9	73
2014 2	80	4	84
2014 1	61	6	67
2013 12	88	9	97
2013 11	84	6	90
2013 10	64	5	69
2013 9	50	7	57
2013 8	84	7	91
2013 7	46	4	50
2013 6	4	3	7
2013 5	4	1	5
2012 8	1	2	3
2011 4	1793	0	1793

Show all

Statistics

Subscribe to our newsletter